Infinity Pharma (INFI) Reports In-Line Q1 EPS

Infinity Pharma (NASDAQ: INFI) reported Q1 EPS of ($0.18), in-line with the analyst estimate of ($0.18).

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79